This study evaluated the efficacy and safety of @entity702 cage implants in cervical reconstruction to treat @entity4720 . Surgical data covered a 4-year period from January 1999 to December 2002 and included 34 consecutive @entity1 , 20 @entity1 and 14 @entity1 , with ages ranging from 27 to 84 years (mean, 57 years). @entity1 underwent anterior cervical microdiscectomy followed by interbody fusion with a @entity702 cage implant (rather than an autogenous iliac crest bone graft) at a single level ranging from C3 to C7. Twenty-one @entity1 had a herniated @entity1798 , nine had @entity179 , and four had previous failed autograft fusion surgery that required revision. At clinical presentation, 26 @entity1 had @entity4048 , 23 had @entity614 , and nine had @entity602 . Diagnostic imaging studies included spinal dynamic roentgenography, computerized tomography, and magnetic resonance imaging. Lesions were located at C3-4 in seven cases, C4-5 in 14 cases, @entity9509 in nine cases, and C6-7 in four cases. The follow-up period ranged from 7 to 48 months (mean, 26 months). Results revealed that the procedure was technically feasible. There were no intra- or @entity260 . The most commonly used cage was 9 mm high. Imaging studies showed no cage instability, migration, or @entity1516 . Although mild subsidence (< 5 mm) was observed in three cases, these @entity1 preserved adequate postoperative cervical @entity1515 and the subsidence did not preclude a good clinical result. The advantages of this procedure over a similar operation using traditional tricorticate bone graft are: no graft morbidity; shorter operation time (mean time saved, 35 minutes); reduced @entity190 (average @entity190 , 75 mL); and early postoperative ambulation (mean, 4.7 hospital days). Nearly all @entity1 rapidly lost their @entity4048 (92%, 24/26) and radicular symptoms (87%, 20/23) after surgery. The recovery rate from @entity602 was 44% (4/9). Progressive bony shield formation over the anterior/posterior cortex (sentinel sign) indicated fusion in five cases.

Preliminary experience with anterior interbody XXXX cage fusion for treatment of cervical disc disease.

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'men'] @entity614 :: ('MESH:D011843', 'Disease') :: ['radiculopathy'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity9509 :: ('3434', 'Gene') :: ['C5-6'] @entity602 :: ('MESH:D013118', 'Disease') :: ['myelopathy'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity1515 :: ('MESH:D008141', 'Disease') :: ['lordosis'] @entity4048 :: ('MESH:D019547', 'Disease') :: ['neck pain'] @entity179 :: ('MESH:D019636', 'Disease') :: ['degenerative disc disease'] @entity702 :: ('MESH:D014025', 'Chemical') :: ['titanium'] @entity1798 :: ('MESH:C535531', 'Disease') :: ['intervertebral disc'] @entity4720 :: ('MESH:D055009', 'Disease') :: ['cervical spondylosis'] @entity1516 :: ('MESH:D011542', 'Disease') :: ['pseudarthrosis']
@entity702 :: (MESH:D014025,Chemical) :: ['titanium']
